BACKGROUND: This study examines gene-environment interaction between the MTHFR C667T polymorphism and folic acid in the etiology of orofacial clefts (OFC). We used a pooled-analytical approach on four studies that used similar methods. METHODS: We used logistic regression to analyze the pooled sample of 1149 isolated cases and 1161 controls. Fetal and maternal MTHFR C677T genotypes, and maternal periconceptional exposure to smoking, alcohol, vitamin containing folic acid and folic acid supplements were contrasted between the cleft types [non-syndromic clefts lip or without cleft palate (CL(P)) and non-syndromic cleft palate (CP)] and control groups. RESULTS: There was a reduced risk of CL(P) with maternal folic acid use (p = 0.008; OR = 0.70, 95% CI: 0.65-0.94) and with supplements containing folic acid (p = 0.028, OR = 0.80, 95% CI: 0.65-0.94). Maternal smoking increased the risk of both CL(P) (p < 10 e-3; OR = 1.62, 95% CI: 1.35-1.95) and CP (p = 0.028; OR = 1.38, 95% CI: 1.04-1.83). No significant risk was observed with either maternal or fetal MTHFR C677T genotypes. CONCLUSION: This individual participant data (IPD) meta-analysis affords greater statistical power and can help alleviate the problems associated with aggregate-level data-sharing. The result of this IPD meta-analysis is consistent with previous reports suggesting that folic acid and smoking influence OFC outcomes.
BACKGROUND: This study examines gene-environment interaction between the MTHFR C667T polymorphism and folic acid in the etiology of orofacial clefts (OFC). We used a pooled-analytical approach on four studies that used similar methods. METHODS: We used logistic regression to analyze the pooled sample of 1149 isolated cases and 1161 controls. Fetal and maternal MTHFRC677T genotypes, and maternal periconceptional exposure to smoking, alcohol, vitamin containing folic acid and folic acid supplements were contrasted between the cleft types [non-syndromic clefts lip or without cleft palate (CL(P)) and non-syndromic cleft palate (CP)] and control groups. RESULTS: There was a reduced risk of CL(P) with maternal folic acid use (p = 0.008; OR = 0.70, 95% CI: 0.65-0.94) and with supplements containing folic acid (p = 0.028, OR = 0.80, 95% CI: 0.65-0.94). Maternal smoking increased the risk of both CL(P) (p < 10 e-3; OR = 1.62, 95% CI: 1.35-1.95) and CP (p = 0.028; OR = 1.38, 95% CI: 1.04-1.83). No significant risk was observed with either maternal or fetal MTHFRC677T genotypes. CONCLUSION: This individual participant data (IPD) meta-analysis affords greater statistical power and can help alleviate the problems associated with aggregate-level data-sharing. The result of this IPD meta-analysis is consistent with previous reports suggesting that folic acid and smoking influence OFC outcomes.
Authors: Allen J Wilcox; Rolv Terje Lie; Kari Solvoll; Jack Taylor; D Robert McConnaughey; Frank Abyholm; Hallvard Vindenes; Stein Emil Vollset; Christian A Drevon Journal: BMJ Date: 2007-01-26
Authors: Isabel Fortier; Dany Doiron; Julian Little; Vincent Ferretti; François L'Heureux; Ronald P Stolk; Bartha M Knoppers; Thomas J Hudson; Paul R Burton Journal: Int J Epidemiol Date: 2011-07-30 Impact factor: 7.196
Authors: Terri H Beaty; Ingo Ruczinski; Jeffrey C Murray; Mary L Marazita; Ronald G Munger; Jacqueline B Hetmanski; Tanda Murray; Richard J Redett; M Daniele Fallin; Kung Yee Liang; Tao Wu; Poorav J Patel; Sheng-Chih Jin; Tian Xiao Zhang; Holger Schwender; Yah Huei Wu-Chou; Philip K Chen; Samuel S Chong; Felicia Cheah; Vincent Yeow; Xiaoqian Ye; Hong Wang; Shangzhi Huang; Ethylin W Jabs; Bing Shi; Allen J Wilcox; Rolv T Lie; Sun Ha Jee; Kaare Christensen; Kimberley F Doheny; Elizabeth W Pugh; Hua Ling; Alan F Scott Journal: Genet Epidemiol Date: 2011-05-26 Impact factor: 2.135
Authors: Oivind Skare; Astanand Jugessur; Rolv Terje Lie; Allen James Wilcox; Jeffrey Clark Murray; Astrid Lunde; Truc Trung Nguyen; Håkon Kristian Gjessing Journal: Ann Hum Genet Date: 2012-05 Impact factor: 1.670
Authors: James L Mills; Anne M Molloy; Anne Parle-McDermott; James F Troendle; Lawrence C Brody; Mary R Conley; Christopher Cox; Faith Pangilinan; David J A Orr; Michael Earley; Eamon McKiernan; Ena C Lynn; Anne Doyle; John M Scott; Peadar N Kirke Journal: Birth Defects Res A Clin Mol Teratol Date: 2008-09
Authors: J Little; M Gilmour; P A Mossey; D Fitzpatrick; A Cardy; J Clayton-Smith; A Hill; S J Duthie; A E Fryer; A M Molloy; J M Scott Journal: Cleft Palate Craniofac J Date: 2007-12-23
Authors: Jennifer R Harris; Paul Burton; Bartha Maria Knoppers; Klaus Lindpaintner; Marianna Bledsoe; Anthony J Brookes; Isabelle Budin-Ljøsne; Rex Chisholm; David Cox; Mylène Deschênes; Isabel Fortier; Pierre Hainaut; Robert Hewitt; Jane Kaye; Jan-Eric Litton; Andres Metspalu; Bill Ollier; Lyle J Palmer; Aarno Palotie; Markus Pasterk; Markus Perola; Peter H J Riegman; Gert-Jan van Ommen; Martin Yuille; Kurt Zatloukal Journal: Eur J Hum Genet Date: 2012-06-20 Impact factor: 4.246
Authors: Nicholas J Marini; Wei Yang; Kripa Asrani; John S Witte; Jasper Rine; Edward J Lammer; Gary M Shaw Journal: Am J Med Genet A Date: 2016-09-08 Impact factor: 2.802
Authors: Semira Gonseth; Gary M Shaw; Ritu Roy; Mark R Segal; Kripa Asrani; Jasper Rine; Joseph Wiemels; Nicholas J Marini Journal: Epigenetics Date: 2019-03-14 Impact factor: 4.528
Authors: Renata Bortolus; Fenneke Blom; Francesca Filippini; Mireille N M van Poppel; Emanuele Leoncini; Denhard J de Smit; Pier Paolo Benetollo; Martina C Cornel; Hermien E K de Walle; Pierpaolo Mastroiacovo Journal: BMC Pregnancy Childbirth Date: 2014-05-13 Impact factor: 3.007